The Paris Bourse is consolidating very slowly (-0.2% towards 8,010pts): prices have fluctuated all day between -0.05% and -0.4% (8,025/7,995) in non-existent volumes (1.1 billion euros), which should mean a session at less than 2.5 billion euros at 5:35 pm (how has the market been able to go so high with so little volume since the end of October 2023?).
If the CAC40 were to freeze at 8,000pts until Friday (the '4 Witches' session), this would allow us to maximize quarterly gains, and even cash in on the 'volat' on the 'calls' and 'puts' sold over the last 15 days, since the CAC40, like many other indices, has gained little ground since February 29.

The CAC40 could thus consolidate 6.5% of its cumulative gains since the start of the year, while the Euro-Stoxx50 (-0.8% this Monday to 4,920) is close to 9%... and the S&P500, which is down by -0.2% (to 5,112), and the Dow Jones by -0.15%.

No European data was on the agenda on Monday, but the following days will see the release of the latest inflation figures in Germany and France for February, as well as industrial production in the eurozone and the UK for January.

However, the week promises to be a busy one for statistics in the United States, with the various inflation figures, as well as retail sales and industrial production for last month.
The decline in oil prices which began on Friday is stalling, after failing once again to break through $83.70 on Thursday (in London, and $80 on the NYMEX): the barrel is down
Bond markets start the week on a heavy note, with OATs and Bunds down +5pts, followed by +5pts of tension on Italian BTPs.
Marginal deterioration on T-Bonds with +1.5pts to 4.1030%.... and gold is still holding firm at $2,180/Oz.

To awaken investors' interest in a rather soporific market, look no further than Bitcoin (+6%), which smashed a new intraday all-time high at $72,690 (72,250 this evening), and - symbolically and for the 1st time - surpassed the value of gold bullion ($71,160)
.
In stock news, Sanofi reports further positive Phase II results for amlitelimab, confirming its potential as a best-in-class drug in terms of maintaining response in the treatment of atopic dermatitis.

Spie announces the signature of an agreement to acquire approximately 92% of ICG Group, a leading German provider of turnkey services in telecoms infrastructure (for the fiber network and 5G mobile telecommunications).

Thales announces an order from France's Direction Générale de l'Armement (DGA), via the Organisation Conjoint de Coopération en matière d'Armement (OCCAr), for a light operations center (e-POC) for the French Navy's drone-based mine countermeasures system.

According to the Financial Times, Kering has begun talks with PAI Partners' eyewear manufacturer Marcolin. According to the FT, other groups in discussion for this acquisition include EssilorLuxottica, Safilo and the Marchon group.

Copyright (c) 2024 CercleFinance.com. All rights reserved.